Search Results - "WONG, Shekman L" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments

by Agarwal, Suresh K., PhD, DiNardo, Courtney D., MD, Potluri, Jalaja, MD, Dunbar, Martin, DrPH, Kantarjian, Hagop M., MD, Humerickhouse, Rod A., MD, PhD, Wong, Shekman L., PhD, Menon, Rajeev M., PhD, Konopleva, Marina Y., MD, PhD, Salem, Ahmed Hamed, PhD
Published in Clinical therapeutics (01.02.2017)

Get full text

Journal Article

Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections

Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections

by SAMARA, Emil, SHAW, Jeng-Pyng, BARRIERE, Steven L, WONG, Shekman L, WORBOYS, Philip
Published in Antimicrobial Agents and Chemotherapy (01.04.2012)

Get full text

Journal Article

Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study

Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study

by Agarwal, Suresh K, Hu, Beibei, Chien, David, Wong, Shekman L, Salem, Ahmed Hamed
Published in Journal of clinical pharmacology (01.11.2016)

Get more information

Journal Article

$Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma$

Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

by Salem, Ahmed Hamed, Agarwal, Suresh K, Dunbar, Martin, Enschede, Sari L Heitner, Humerickhouse, Rod A, Wong, Shekman L
Published in Journal of clinical pharmacology (01.04.2017)

Get more information

Journal Article

Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor

Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor

by Salem, Ahmed Hamed, Agarwal, Suresh K, Dunbar, Martin, Nuthalapati, Silpa, Chien, David, Freise, Kevin J, Wong, Shekman L
Published in Journal of clinical pharmacology (01.11.2016)

Get more information

Journal Article

Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [ 14 C]-Labeled Microtracers with Separate Labeling Positions

Characterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [ 14 C]-Labeled Microtracers with Separate Labeling Positions

by Yang, Ziping, Wong, Shekman L., Cha, David, Wilfret, David, Turnquist, David, Plummer, Andrew, van Ingen, Eric, Kearney, Brian P.
Published in Drug metabolism and disposition (01.12.2023)

Get full text

Journal Article

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL‐2 inhibitor, in patients with non‐Hodgkin lymphoma

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL‐2 inhibitor, in patients with non‐Hodgkin lymphoma

by Agarwal, Suresh K., Salem, Ahmed Hamed, Danilov, Alexey V., Hu, Beibei, Puvvada, Soham, Gutierrez, Martin, Chien, David, Lewis, Lionel D., Wong, Shekman L.
Published in British journal of clinical pharmacology (01.04.2017)

Get full text

Journal Article

Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers

Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers

by Rodvold, Keith A, Gotfried, Mark H, Ussery, Xilla T, Wong, Shekman L, Hamed, Kamal A
Published in Antimicrobial agents and chemotherapy (01.10.2024)

Get full text

Journal Article

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis

Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin’s Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis

by Jones, Aksana K., Freise, Kevin J., Agarwal, Suresh K., Humerickhouse, Rod A., Wong, Shekman L., Salem, Ahmed Hamed
Published in The AAPS journal (01.09.2016)

Get full text

Journal Article

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

by Liu, Hong, Michmerhuizen, Melissa J, Lao, Yanbin, Wan, Katty, Salem, Ahmed Hamed, Sawicki, James, Serby, Michael, Vaidyanathan, Srirajan, Wong, Shekman L, Agarwal, Suresh, Dunbar, Martin, Sydor, Jens, de Morais, Sonia M, Lee, Anthony J
Published in Drug metabolism and disposition (01.03.2017)

Get full text

Journal Article

$Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia$

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

by Freise, Kevin J., Jones, Aksana K., Eckert, Doerthe, Mensing, Sven, Wong, Shekman L., Humerickhouse, Rod A., Awni, Walid M., Salem, Ahmed Hamed
Published in Clinical pharmacokinetics (01.05.2017)

Get full text

Journal Article

Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment

Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment

by Worboys, Philip D., Wong, Shekman L., Barriere, Steven L.
Published in European journal of clinical pharmacology (01.06.2015)

Get full text

Journal Article

Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers

Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers

by Salem, Ahmed Hamed, Hu, Beibei, Freise, Kevin J., Agarwal, Suresh K., Sidhu, Dilraj S., Wong, Shekman L.
Published in Clinical drug investigation (01.03.2017)

Get full text

Journal Article

Pharmacokinetics of Subcutaneous Recombinant Methionyl Human Leptin Administration in Healthy Subjects in the Fed and Fasting States: Regulation by Gender and Adiposity

Pharmacokinetics of Subcutaneous Recombinant Methionyl Human Leptin Administration in Healthy Subjects in the Fed and Fasting States: Regulation by Gender and Adiposity

by Chan, Jean L., Wong, Shekman L., Mantzoros, Christos S.
Published in Clinical pharmacokinetics (01.01.2008)

Get full text

Journal Article

Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects

Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects

by Wong, Shekman L., Barriere, Steven L., Kitt, Michael M., Goldberg, Michael R.
Published in Journal of antimicrobial chemotherapy (01.10.2008)

Get full text

Journal Article

Single-dose pharmacokinetics and tolerability of telavancin in elderly men and women

Single-dose pharmacokinetics and tolerability of telavancin in elderly men and women

by Goldberg, Michael R, Wong, Shekman L, Shaw, Jeng-Pyng, Kitt, Michael M, Barriere, Steven L
Published in Pharmacotherapy (01.08.2010)

Get more information

Journal Article

Pharmacokinetics of Recombinant Methionyl Human Leptin after Subcutaneous Administration: Variation of Concentration-Dependent Parameters According to Assay

Pharmacokinetics of Recombinant Methionyl Human Leptin after Subcutaneous Administration: Variation of Concentration-Dependent Parameters According to Assay

by Chan, Jean L., Wong, Shekman L., Orlova, Christine, Raciti, Patricia, Mantzoros, Christos S.
Published in The journal of clinical endocrinology and metabolism (01.06.2007)

Get full text

Journal Article

Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects

Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects

by Wong, Shekman L, Goldberg, Michael R, Ballow, Charles H, Kitt, Michael M, Barriere, Steven L
Published in Pharmacotherapy (01.02.2010)

Get more information

Journal Article

Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancin

Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancin

by Goldberg, Michael R, Wong, Shekman L, Shaw, Jeng-Pyng, Kitt, Michael M, Barriere, Steven L
Published in Pharmacotherapy (01.01.2010)

Get more information

Journal Article

Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants

Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants

by Wong, Shekman L, Sörgel, Fritz, Kinzig, Martina, Goldberg, Michael R, Kitt, Michael M, Barriere, Steven L
Published in Journal of clinical pharmacology (01.07.2009)

Get more information

Journal Article